Skip to main content
Fig. 2 | Diabetology & Metabolic Syndrome

Fig. 2

From: Mitigating iftar-related glycemic excursions in adolescents and young adults with type 1 diabetes on MiniMedâ„¢ 780G advanced hybrid closed loop system: a randomized clinical trial for adjunctive oral vildagliptin therapy during Ramadan fasting

Fig. 2

AHCL system performance showing glucose control between vildagliptin and control groups at baseline and at the end of Ramadan among the enrolled patients with type 1 diabetes on MiniMedâ„¢ 780G. Glucose values are shown as percentage of time spent in ranges during the study period

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us